AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $13.60.
AHCO has been the topic of several recent analyst reports. Wall Street Zen upgraded AdaptHealth from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 17th. Weiss Ratings upgraded AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday. Zacks Research upgraded AdaptHealth from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Finally, Canaccord Genuity Group upped their price target on shares of AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a report on Thursday, November 6th.
View Our Latest Report on AdaptHealth
Insider Buying and Selling
Institutional Trading of AdaptHealth
A number of large investors have recently modified their holdings of AHCO. Janney Montgomery Scott LLC grew its holdings in shares of AdaptHealth by 1.9% during the second quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock valued at $757,000 after buying an additional 1,511 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in AdaptHealth by 6.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock worth $256,000 after acquiring an additional 1,671 shares during the period. CWM LLC grew its stake in AdaptHealth by 17.5% during the 3rd quarter. CWM LLC now owns 12,306 shares of the company’s stock valued at $110,000 after purchasing an additional 1,835 shares during the last quarter. Arizona State Retirement System increased its holdings in shares of AdaptHealth by 9.3% in the third quarter. Arizona State Retirement System now owns 27,937 shares of the company’s stock valued at $250,000 after purchasing an additional 2,367 shares during the period. Finally, State of Alaska Department of Revenue increased its holdings in shares of AdaptHealth by 4.0% in the second quarter. State of Alaska Department of Revenue now owns 62,807 shares of the company’s stock valued at $592,000 after purchasing an additional 2,418 shares during the period. Hedge funds and other institutional investors own 82.67% of the company’s stock.
AdaptHealth Price Performance
AHCO stock opened at $10.10 on Friday. The stock has a market cap of $1.37 billion, a PE ratio of 18.36, a P/E/G ratio of 1.14 and a beta of 1.72. AdaptHealth has a 12 month low of $7.11 and a 12 month high of $11.63. The company has a 50-day moving average price of $10.09 and a 200 day moving average price of $9.56. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 1.09.
AdaptHealth (NASDAQ:AHCO – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.05). AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The firm had revenue of $820.31 million during the quarter, compared to the consensus estimate of $799.62 million. During the same period in the previous year, the business earned $0.15 EPS. The firm’s revenue for the quarter was up 1.8% on a year-over-year basis. Equities research analysts anticipate that AdaptHealth will post 0.88 earnings per share for the current year.
About AdaptHealth
AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.
The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.
Featured Articles
- Five stocks we like better than AdaptHealth
- The day the gold market broke
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
